MedPath

ACTAEA RACEMOSA

ACTAEA RACEMOSA

Discontinued
DIN Number

N/A

Drug Class

Human

Market Date

Jan 5, 1998

Company
HC

dolisos canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
AIG Number0107242003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormGlobules ,  Liquid ,  Granules
Route of AdministrationOral
AHFS Classification92:02.00* See footnote6
Health Canada Classification

ACTIVE INGREDIENTS (1)

CIMICIFUGA RACEMOSAActive
Strength: 1 X
Monograph: CIMICIFUGA RACEMOSA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.